Search results for “Adenosine A2A receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 810 patents, we discovered top 113 key players by total patent application. Novartis AG, Pfizer Inc., CV Therapeutics, Inc. are dominant in this area. They take 18.27% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 64
Pfizer Inc.
New York, United States
Patent: 44
CV Therapeutics, Inc.
California, United States
Patent: 40
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 36
Kyowa Kirin Co., Ltd.
Tokyo-to, Japan
Patent: 35
Corvus Pharmaceuticals, Inc.
California, United States
Patent: 35
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 35
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 27
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 25
Can-Fite BioPharma Ltd.
Israel
Patent: 24
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 5 start-ups by total patent application. Adorx Therapeutics Ltd., Institut National de la Santé et de la Recherche Médicale, Standigm Co. Ltd. are active in this area.
STARTUP
Adorx Therapeutics Ltd.
EDINBURGH, United Kingdom
Patent: 9
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 4
STARTUP
Standigm Co. Ltd.
South Korea
Patent: 2
STARTUP
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 2
STARTUP
Shenzhen Hand Hitech Network Technology Co. Ltd.
Guangdong Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 144 patents applied in the last 5 years. We discover 34 most active companies in this area. The fast-growing Corvus Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Arcus Biosciences, Inc. take 44.44% of patent filing during this period.
Corvus Pharmaceuticals, Inc.
California, United States
Patent: 34
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 20
Arcus Biosciences, Inc.
California, United States
Patent: 10
STARTUP
Adorx Therapeutics Ltd.
EDINBURGH, United Kingdom
Patent: 9
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 8
Twist Bioscience Corp.
California, United States
Patent: 5
Nankai University
Tianjin Shi, China
Patent: 4
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 4
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 4
Palo Biofarma SL
Spain
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 144 patents in last 5 years, we discover 25 new entrants. Arcus Biosciences, Inc., Adorx Therapeutics Ltd., Merck Sharp & Dohme LLC are the most active new entrants in this area.
Arcus Biosciences, Inc.
California, United States
Patent: 10
STARTUP
Adorx Therapeutics Ltd.
EDINBURGH, United Kingdom
Patent: 9
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 8
Twist Bioscience Corp.
California, United States
Patent: 5
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 4
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 4
Shanghaitech University
Shanghai Shi, China
Patent: 3
Guangzhou Maxinovel Pharmaceiticals Co Ltd
Guangdong Sheng, China
Patent: 2
Shanghai Haiyan Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 2
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 99 patents, we discovered top 28 universities and scientific research institutions by total patent application. University of Padua, University of Milan, Cornell University are dominant in this area. They take 33.33% of the total patent filing.
University of Padua
Italy
Patent: 11
University of Milan
Lombardia, Italy
Patent: 8
Cornell University
New York, United States
Patent: 6
New York University
New York, United States
Patent: 5
Nankai University
Tianjin Shi, China
Patent: 5
University of Barcelona
Spain
Patent: 4
Université d'Aix-Marseille
France
Patent: 4
Vanderbilt University
Tennessee, United States
Patent: 3
Shanghaitech University
Shanghai Shi, China
Patent: 3
The Garvan Institute of Medical Research
New South Wales, Australia
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: